Coya Therapeutics, Inc. Profile Avatar - Palmy Investing

Coya Therapeutics, Inc.

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enh…

Biotechnology
US, Houston [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Coya Therapeutics, Inc. can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
16,707,441
Volume
71,918
Volume on Avg.
94,936
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $5.58 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of COYA's Analysis
CIK: 1835022 CUSIP: - ISIN: US22407B1089 LEI: - UEI: -
Secondary Listings
COYA has no secondary listings inside our databases.